US Broker Ratings

Personalis, Inc. (PSNL) Stock Analysis: Navigating Challenges with Strategic Collaborations and Innovative Genomic Solutions

Personalis, Inc. (NASDAQ: PSNL) stands at a critical juncture, with its current stock price at $10.72 and a 52-week range spanning from $3.00 to a high..

Nutex Health Inc. (NUTX) Investor Outlook: Analyzing the 239.90% Revenue Growth and 121.63% Upside Potential

Nutex Health Inc. (NUTX), a dynamic player in the healthcare sector, is catching the attention of investors with its impressive 239.90% revenue growth and a noteworthy..

Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: Unraveling a 129.98% Potential Upside

Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a clinical-stage biopharmaceutical company, stands at an intriguing crossroads for investors, presenting a compelling opportunity with substantial potential upside. Specializing in..

Bicycle Therapeutics plc (BCYC) Stock Analysis: Unveiling a 184.79% Potential Upside

Bicycle Therapeutics plc (NASDAQ: BCYC), a pioneer in the biotechnology sector, is capturing investor attention with an impressive potential upside of 184.79%. As a clinical-stage pharmaceutical..

Bicara Therapeutics Inc. (BCAX) Stock Analysis: Exploring a 71% Upside in the Biotech Sector

Bicara Therapeutics Inc. (BCAX), a burgeoning player in the biotechnology industry, has captured the attention of investors with its potential for significant upside. As a clinical-stage..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Navigating Growth Amid a Challenging Landscape

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a key player in the biotechnology sector, presents a captivating case for investors who are keen on exploring opportunities in..

Delcath Systems, Inc. (DCTH) Stock Analysis: A Closer Look at Its 131% Potential Upside

Delcath Systems, Inc. (NASDAQ: DCTH) has been drawing significant attention in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $340.42..

Enhabit, Inc. (EHAB) Stock Analysis: Assessing Growth Potential Amidst a 5.20% Upside

Enhabit, Inc. (NASDAQ: EHAB), a prominent player in the healthcare sector, specializes in providing essential home health and hospice services across the United States. With a..

Kura Oncology, Inc. (KURA): Investor Outlook Reveals a Striking 175% Potential Upside

Kura Oncology, Inc. (NASDAQ: KURA), a promising player in the biotechnology sector, is drawing significant attention from investors with its potential for substantial upside. Specializing in..

Semler Scientific Inc. (SMLR) Stock Analysis: A 217% Potential Upside That Intrigues Investors

Semler Scientific, Inc. (NASDAQ: SMLR) is capturing the attention of investors with a tantalizing potential upside of 217.54%, based on analyst ratings. This healthcare-sector company, specializing..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: Strong Buy Ratings and Impressive Revenue Growth Highlight Growth Potential

Stoke Therapeutics, Inc. (NASDAQ: STOK), a promising player in the biotechnology sector, has caught the attention of investors with its innovative approach to tackling severe genetic..

Investor Outlook: Arvinas, Inc. (ARVN) Navigates Challenges with Cutting-Edge Biotech Innovation

Arvinas, Inc. (NASDAQ: ARVN), a clinical-stage biotechnology firm from New Haven, Connecticut, is at the forefront of an innovative wave in healthcare, leveraging PROTAC technology to..

REGENXBIO Inc. (RGNX) Stock Analysis: A Biotech with 122.82% Potential Upside and Promising Clinical Pipeline

REGENXBIO Inc. (NASDAQ: RGNX) stands out in the biotechnology sector, showcasing a robust growth potential that has caught the attention of investors. With a market capitalization..

Butterfly Network, Inc. (BFLY) Stock Analysis: A Promising Upside of 27% in the Medical Device Arena

For investors with a keen eye on the healthcare sector, Butterfly Network, Inc. (NYSE: BFLY) offers a compelling prospect in the medical devices industry. Known for..

Ginkgo Bioworks Holdings, Inc. (DNA) Investor Outlook: Analyzing a 17% Potential Upside Amidst Market Challenges

Ginkgo Bioworks Holdings, Inc. (NASDAQ: DNA) presents a complex yet intriguing proposition for investors navigating the ever-evolving biotechnology sector. As a prominent player in the realm..

Auna SA (AUNA) Stock Analysis: High Potential Upside with 123% Target Growth

Auna S.A. (AUNA), a healthcare service provider headquartered in Luxembourg, presents an intriguing opportunity for investors with its remarkable potential upside. Operating hospitals and clinics in..

Orthofix Medical Inc. (OFIX) Stock Analysis: 41% Potential Upside Beckons Investors

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the healthcare sector specializing in medical devices, presents a compelling opportunity for investors with a potential upside..

Evolus, Inc. (EOLS) Investor Outlook: Unveiling a 165% Potential Upside in the Performance Beauty Sector

Evolus, Inc. (NASDAQ: EOLS) is capturing investor attention with its significant potential upside of over 165%, presenting a compelling case for those looking to invest in..

Valneva SE (VALN) Stock Analysis: Exploring a 20% Potential Upside in the Biotech Sector

Valneva SE (NASDAQ: VALN), a prominent player in the biotechnology industry, has been capturing investor attention with its focus on developing vaccines for infectious diseases with..

Neuropace, Inc. (NPCE) Investor Outlook: Analyst Consensus and 6% Potential Upside

Neuropace, Inc. (NASDAQ: NPCE), a pioneering player in the medical device industry, is drawing significant interest from the investment community. Specializing in innovative treatments for drug-resistant..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds